Related Experiment Video
Updated: Jan 25, 2026

Multi-target Parallel Processing Approach for Gene-to-structure Determination of the Influenza Polymerase PB2 Subunit
Published on: June 28, 2013
Targeting Caspase 8: Using Structural and Ligand-Based Approaches to Identify Potential Leads for the Treatment of
Khurshid Ahmad1, Vishal M Balaramnavar2, Navaneet Chaturvedi3
1Department of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, Korea. ahmadkhursheed2008@gmail.com.
Abstract:
Caspase 8 is a central player in the apoptotic cell death pathway and is also essential for cytokine processing. The critical role of this protease in cell death pathways has generated research interest because its activation has also been linked with neural cell death. Thus, blocking the activity of caspase 8 is considered a potential therapy for neurodegenerative diseases. To extend the repertoire of caspase 8 inhibitors, we employed several computational approaches to identify potential caspase 8 inhibitors. Based on the structural information of reported inhibitors, we designed several individual and consensus pharmacophore models and then screened the ZINC database, which contains 105,480 compounds. Screening generated 5332 candidates, but after applying stringent criteria only two candidate compounds, ZINC19370490 and ZINC04534268, were evaluated by molecular dynamics simulations and subjected to Molecular Mechanics/Poisson Boltzmann Surface Area (MM-PBSA) analysis. These compounds were stable throughout simulations and interacted with targeted protein by forming hydrogen and van der Waal bonds. MM-PBSA analysis showed that these compounds were comparable or better than reported caspase 8 inhibitors. Furthermore, their physical properties were found to be acceptable, and they are non-toxic according to the ADMET online server. We suggest that the inhibitory efficacies of ZINC19370490 and ZINC04534268 be subjected to experimental validation.
Insights
Researchers identified two novel compounds, ZINC19370490 and ZINC04534268, as potential inhibitors of caspase 8. These compounds show promise for treating neurodegenerative diseases by blocking neural cell death pathways.
Area of Science:
- Biochemistry
- Computational Chemistry
- Neuroscience
Background:
- Caspase 8 is crucial for apoptosis and cytokine processing.
- Its activation is linked to neural cell death, making it a therapeutic target for neurodegenerative diseases.
Purpose of the Study:
- To discover novel inhibitors of caspase 8 using computational methods.
- To identify potential drug candidates for neurodegenerative disease therapy.
Main Methods:
- Designed pharmacophore models based on known inhibitors.
- Screened the ZINC database for potential drug candidates.
- Evaluated top candidates using molecular dynamics simulations and MM-PBSA analysis.
Main Results:
- Identified two promising compounds: ZINC19370490 and ZINC04534268.
- These compounds demonstrated stability and favorable interactions with caspase 8.
- MM-PBSA analysis indicated inhibitory potential comparable to or exceeding existing inhibitors.
- Compounds possess acceptable physical properties and predicted non-toxicity.
Conclusions:
- ZINC19370490 and ZINC04534268 are potential lead compounds for caspase 8 inhibition.
- Further experimental validation is recommended to confirm their therapeutic efficacy in neurodegenerative diseases.
Related Concept Videos
Metal-Ligand Bonds
In these complexes, transition metals form coordinate covalent bonds, a kind of Lewis acid-base interaction in which both of the electrons in the bond are contributed by a donor (Lewis base) to an electron acceptor (Lewis acid). The Lewis acid in...
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Ligand Binding and Linkage
Caspases
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...

